Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 352 entries
View as:

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02998554 Org: User:
Start: 03/28/17 End: 05/16/19 Due: 05/16/20

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT03260205 Org: User:
Start: 09/06/17 End: 10/23/18 Due: 10/23/19

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Phase: N/A Priority: Normal
NCT ID: NCT04130191 Org: User:
Start: 12/11/19 End: 09/09/24 Due: 09/09/25

FIRAZYR General Drug Use-Results Survey (Japan)

Phase: N/A Priority: Normal
NCT ID: NCT04057131 Org: User:
Start: 11/20/18 End: 07/29/24 Due: 07/29/25

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

Phase: N/A Priority: Normal
NCT ID: NCT00930644 Org: User:
Start: 09/21/09 End: 01/24/13 Due: 01/24/14

Open Label Extension Study of PREOS

Phase: N/A Priority: Normal
NCT ID: NCT00172133 Org: User:
Start: 10/16/01 End: 04/13/05 Due: 04/13/06

Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03150108 Org: User:
Start: 05/16/17 End: 06/26/17 Due: 06/26/18

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00735371 Org: User:
Start: 10/08/08 End: 04/06/09 Due: 04/06/10

A Study of Replagal in Children and Adults With Fabry Disease in India

Phase: N/A Priority: Normal
NCT ID: NCT05067868 Org: User:
Start: 11/01/22 End: 11/30/26 Due: 11/30/27

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT01363908 Org: User:
Start: 08/10/11 End: 05/13/14 Due: 05/13/15

Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01716455 Org: User:
Start: 10/29/12 End: 03/10/13 Due: 03/10/14

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01234298 Org: User:
Start: 01/27/12 End: 02/24/14 Due: 02/24/15

Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT01842841 Org: User:
Start: 03/13/13 End: 10/08/14 Due: 10/08/15

A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04465396 Org: User:
Start: 01/13/21 End: 08/20/21 Due: 08/20/22

Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03571516 Org: User:
Start: 08/31/18 End: 09/24/20 Due: 09/24/21

Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase

Phase: N/A Priority: Normal
NCT ID: NCT00478647 Org: User:
Start: 07/25/07 End: 06/26/09 Due: 06/26/10

Treatment of Iron Overload Requiring Chelation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01927913 Org: User:
Start: 11/20/14 End: 10/30/15 Due: 10/30/16

SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01760889 Org: User:
Start: 02/01/13 End: 04/01/13 Due: 04/01/14

Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)

Phase: N/A Priority: Normal
NCT ID: NCT00391625 Org: User:
Start: 09/13/04 End: 01/31/08 Due: 01/31/09

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00557960 Org: User:
Start: 02/25/04 End: 10/25/04 Due: 10/25/05

FST-201 In The Treatment of Acute Otitis Externa

Phase: N/A Priority: Normal
NCT ID: NCT00945802 Org: User:
Start: 07/31/09 End: 07/31/10 Due: 07/31/11

Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®

Phase: N/A Priority: Normal
NCT ID: NCT00937794 Org: User:
Start: 07/02/09 End: 07/13/11 Due: 07/13/12

IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity

Phase: N/A Priority: Normal
NCT ID: NCT01096784 Org: User:
Start: 06/18/10 End: 03/30/16 Due: 03/30/17

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

Phase: N/A Priority: Normal
NCT ID: NCT01268098 Org: User:
Start: 02/09/11 End: 11/11/11 Due: 11/11/12

Safety and Efficacy Study of rhPTH(1-84) in Subjects With Hypoparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT03364738 Org: User:
Start: 09/26/18 End: 04/14/20 Due: 04/14/21